#ophthalmology #optics #eyehealth #Santen #Ryjunea #paediatricmyopia #childhoodmyopia #marketingauthorisation #atropineeyedrop #childhoodeyecare #managingmyopia #children #myopiaprogression #SydnexisInc #phase3starstudy #shortsightedness #severeeyeconditions
pharmatimes.com/news/europea...
pharmatimes.com/news/europea...
EC approves Santen’s Ryjunea to slow progression of paediatric myopia - PharmaTimes
Therapy indicated for children aged 3 to 14 at treatment initiation
pharmatimes.com
June 5, 2025 at 10:12 AM
A novel spectacle lens designed to induce peripheral myopic defocus significantly slows #MyopiaProgression and #AxialElongation older than 24 months in #ChildrenWithMyopia, according to study findings published in Eye.
Learn more: https://bit.ly/3PVaofC
#OptometryAdvisor
Learn more: https://bit.ly/3PVaofC
#OptometryAdvisor
Novel Spectacle Lens Slows Myopia Progression and Axial Elongation in Children
A novel spectacle lens designed to induce peripheral myopic defocus can significantly slow myopia progression in children over 24 months.
bit.ly
June 3, 2026 at 8:24 PM
A novel spectacle lens designed to induce peripheral myopic defocus significantly slows #MyopiaProgression and #AxialElongation older than 24 months in #ChildrenWithMyopia, according to study findings published in Eye.
Learn more: https://bit.ly/3PVaofC
#OptometryAdvisor
Learn more: https://bit.ly/3PVaofC
#OptometryAdvisor